There is a low diversification of 12 months returns within the 'Real Estate'. The sector is around 19 percent higher since January. Among the winners we find Kodiak Sciences, Silence Therapeutics and Avita Medical. Relatively big losses are for Organogenesis Holdings, OpGen and Mologen AG.
The winners in this sector are the midcaps, while smallcaps are mostly among the less performers.
Regarding the price/earnings-ratios we see a spread palette. The megacaps are with the price/earnings-ratio of 41 the most expensive. The smallcaps are the cheapest and trade at 18 times the earnings per share. Abcam, Diaceutics and Genus are the stocks with the highest ratios. Stocks with the lowest ratios are Assertio Therapeutics, Endo International and Lexicon Pharmaceuticals.
The sector's average dividend yield is with 3,9 percent relatively high. Stocks now high dividend yields now are Abbvie, Gilead Sciences and Bayer AG.
This is a free publication from Valuespectrum Pro. Valuespectrum Pro is a professional platform with analyses from all US and European companies. Click here to sign up for free.